No abstract

No abstract

Purpose To our knowledge, only one study has assessed Quality of Life (QOL) as a predictor of return to work (RTW) during breast cancer treatment and one has evaluated multidimensional cancer‐related fatigue (CRF) as a determinant of RTW. However, no study has assessed the impact of changes in these variables on RTW. The objective of this study was to evaluate QOL, multidimensional CRF and changes in these variables as determinants of RTW during breast cancer treatment. Methods We performed a longitudinal study of 68 patients with a mean age of 46.97 years (SD = 6.92), who were employed at the time of diagnosis. Women were assessed at the beginning of adjuvant treatments (T0) and followed up with by telephone at three (T1) and 6 months later (T2), using questionnaires (QLQ‐C30; MFI‐20). Results Global QOL, OR = 1.12 [1.01–1.25], sleep disturbance, OR = 1.04 [1.002–1.08], fatigue (QLQ‐C30), OR = 0.93 [0.88–0.99], nausea‐vomiting, OR = 0.84 [0.73–0.97], reduced motivation, OR = 1.49 [1.05–2.11] and general fatigue, OR = 0.79 [0.63–0.99] at T0 were associated with RTW at T1. At T2 global QOL, OR = 1.09 [1.01–1.17], cognitive functioning, OR = 1.10 [1.03–1.17], general fatigue, OR = 1.82 [1.04–3.17] and mental fatigue, OR = 0.29 [0.11–0.81] were associated with RTW. Furthermore, changes in mental fatigue were associated with RTW at T2, OR = 0.02 [0.001–0.29]. Conclusions Quality of life, fatigue and their changes in them, especially cognitive functioning and mental fatigue, can play an important role in predicting the RTW of women with breast cancer. This confirms the importance of multidisciplinary care for cancer and the emergence of a theoretical psychological model of RTW.

No abstract

No abstract

No abstract

Objectif : Les études qui s’interrogent sur l’efficacité des interventions non médicamenteuses, dans la prise en charge de la fatigue associée au cancer, comprennent le plus souvent des sessions d’activités physiques adaptées ou des prises en charge psychologiques. Parmi elles se trouve l’hypnose, mais elle est principalement proposée en combinaison avec une autre thérapie, limitant une interprétation en termes d’efficacité. À travers cette revue de la littérature, nous voulons comprendre quelle est la place de l’hypnose pour la prise en charge de la fatigue associée au cancer. Méthode : Nous avons recherché les articles scientifiques indexés dans les bases de données Cochrane, PsycINFO, Pubmed et Web of Science. Les principaux mots clés étaient « fatigue », « cancer » et « hypnosis ». La qualité méthodologique des études a été évaluée. Résultats : Quatre-vingt-deux études ont été recensées. Après sélection, 11 études ont été retenues à la lecture. Les résultats sur l’efficacité de l’hypnose seule (non combinée à une autre thérapie) ont porté sur 6 études. Bien qu’il faille distinguer l’hypnose délivrée par autrui, de l’autohypnose par audioenregistrement, nos résultats indiquent que 4 études rapportent une efficacité significative de l’hypnose pour réduire la fatigue des patients soignés pour un cancer. Conclusion : Au niveau international, trop peu d’études évaluent l’efficacité de l’hypnose en oncologie. Ainsi, sur un symptôme spécifique comme la fatigue, les études se font encore plus rares. De plus, il est difficile d’évaluer l’efficacité d’une méthode pour laquelle l’homogénéisation de la procédure est difficile à mettre en place. Cependant, au regard de cette étude, l’hypnose présente un réel intérêt et une efficacité dans la réduction des symptômes de fatigue.

University students are a vulnerable population, and many recent studies show that anxiety, depressive symptoms, and academic burnout have been on the increase since the beginning of the COVID-19 pandemic. These findings point to a need for interventions to reduce these difficulties. The purpose of the present study was to assess the effects of 2 formats of an innovative program on students’ mental health (anxiety, depressive symptoms, and academic burnout), intolerance of uncertainty, learned helplessness, and learning. Our sample was composed of 105 university students, recruited on a voluntary basis. They were divided into 3 groups: online intervention group (n = 36), face-to-face intervention group (n = 32), and control group (n = 37). The following variables were measured through online questionnaires: anxiety and depressive symptoms, academic burnout, intolerance of uncertainty, learned helplessness, perceived social support, learning strategies, and beliefs. There were 2 assessments 10 weeks apart (ie, before and after the program in the case of the 2 intervention groups). We performed nonparametric analyses to run comparisons between the 2 assessment timepoints in each group. Results showed that participants in the 2 intervention groups had lower levels of learned helplessness and intolerance of uncertainty at the end of the program. Furthermore, participants in the face-to-face group reported higher levels of perceived social support, academic self-efficacy, and help-seeking strategies. The present study highlighted the benefits of our innovative program, especially its face-to-face format. Clinical Trial - ID: NCT04978194.